NEW YORK (GenomeWeb News) – Scientific publishing firm Elsevier today announced it is buying the assets of genomics analysis firm Ariadne Genomics for an undisclosed amount.
Headquartered in Rockville, Md., Ariadne's flagship product is Pathway Studio for the analyses of molecular pathways and disease progression. The software suite comprises an integrated data mining and visualization product "that organizes relevant facts and relationships from large document collections of genes, proteins, cell processes, and diseases," Elsevier said in a statement.
Pathway Studio enables visualization of biological relationships spanning biomedical literature and helps researchers interpret experimental results using domain-specific ontologies, taxonomies, and dictionaries.
Ariadne will be integrated with Elsevier's Corporate Markets division.